Malignant Peritoneal Neoplasm Recruiting Phase 1 Trials for Bosutinib (DB06616)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03023319Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid TumorsTreatment